Gujarat Themis Biosyn informs about outcome off board meeting

11 Feb 2022 Evaluate
Gujarat Themis Biosyn has informed that Board of Directors at its meeting held today, considered and approved the following matters: Unaudited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2021. A copy of Unaudited Financial Results of the Company for the Quarter & Nine months ended 31st December, 2021 together with Limited Review Report is enclosed herewith; and appointed Hspn & Associates LLP., Practicing Company Secretary as Secretarial Auditor for the purpose of conducting Secretarial Audit for the financial year 2021-22.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

367.90 -11.50 (-3.03%)
13-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.80
Dr. Reddys Lab 1190.35
Cipla 1447.60
Zydus Lifesciences 900.25
Lupin 2176.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×